(±)-B[a]P-7,8-diol | 7,12-DMBA-3,4-diol | DB[a,l]P-11,12-diol | 5-Methychrysene-1,2-diol | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | |
CYP1A1 | 1.9 | 2090 | 1100 | 3.0 | 2180 | 730 | 2.8 | 1600 | 570 | 2.1 | 1520 | 730 |
CYP1B1*1 | 1.4 | 1290 | 920 | 3.5 | 1850 | 530 | 2.5 | 1630 | 650 | 2.7 | 1460 | 540 |
CYP1B1*2 | 1.9 | 1390 | 730 | 4.0 | 2774 | 690 | 2.3 | 1750 | 760 | 3.9 | 1940 | 500 |
CYP1B1*3 | 2.6 | 2270 | 870 | 3.2 | 1850 | 590 | 2.4 | 1610 | 670 | 4.0 | 2000 | 500 |
CYP1B1*6 | 2.2 | 1940 | 880 | 3.6 | 2347 | 650 | 3.7 | 2690 | 730 | 2.2 | 1660 | 750 |
B[a]P | 7,12-DMBA | DB[a,l]P | 5-Methychrysene | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | Km | Vmax | Vmax/Km | |
CYP1A1 | 7.3 | 150 | 20 | 1.5 | 620 | 420 | 2.9 | 940 | 330 | 4.0 | 600 | 150 |
CYP1B1*1 | 5.1 | 160 | 31 | 1.1 | 270 | 240 | 2.9 | 96 | 33 | 5.0 | 290 | 57 |
CYP1B1*2 | 7.4 | 440 | 60 | 1.3 | 440 | 340 | 5.9 | 83 | 14 | 7.0 | 440 | 63 |
CYP1B1*3 | 3.8 | 450 | 119 | 1.3 | 380 | 290 | 3.8 | 84 | 22 | 4.3 | 250 | 58 |
CYP1B1*6 | 5.5 | 220 | 39 | 2.2 | 290 | 130 | 4.4 | 110 | 25 | 4.5 | 250 | 56 |
Substrate concentrations used for PAH dihydrodiols were 0.6, 1.2, 1.8, and 2.4 μM and those for PAH were 1, 3.1, 6.2, 12.5, 25 μM.Km, μM; Vmax, umuunits/min/nmol of P450.